Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, Apr 1997, 802-807, Vol 41, No. 4
R Mazzolla, R Barluzzi, A Brozzetti, JR Boelaert, T Luna, S Saleppico, F Bistoni and E Blasi
Although the pathogenesis of cerebral cryptococcosis is poorly understood,
local immune cells, such as microglia and astrocytes, likely play a
critical role in containing infection. Chloroquine (CQ) is a weak base that
accumulates within acidic vacuoles and increases their pH. Consequently,
proteolytic activity of lysosomal enzymes and intracellular iron
release/availability are impaired, resulting in decreased availability of
nutrients crucial to microorganism survival and growth in the host. We
found that CQ enhances BV2 microglial-cell- mediated anticryptococcal
activity in vitro. The phenomenon is (i) evident when both unopsonized and
opsonized microorganisms are used and (ii) mimicked by NH4Cl, another weak
base, and by bafilomycin A1, an inhibitor of vacuolar-type H+-ATPases. In
vivo, intracerebral administration of CQ before lethal local challenge with
Cryptococcus neoformans results in a significant augmentation of median
survival time and a marked reduction of yeast growth in the brain and is
associated with the enhancement of local interleukin 1beta (IL-1beta) and
IL-6 mRNA transcripts. Overall, these results provide the first evidence
that CQ enhances anticryptococcal host defenses.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Enhanced resistance to Cryptococcus neoformans infection induced by chloroquine in a murine model of meningoencephalitis
Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Italy.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»